Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study

doi:10.3748/wjg.v13.i47.6356

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 47

This Article

(0)

(5300)

(50)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Liver Cancer

World J Gastroenterol. Dec 21, 2007; 13(47): 6356-6364
Published online Dec 21, 2007. doi: 10.3748/wjg.v13.i47.6356

Table 5 Diagnostic value of quantitative CHI for detection of malignant hepatic tumors in different phases after intravenous application of ultrasound contrast agent

	Arterial phase	Portal-venous phase	Late venous phase
Specificity (%)	53.7	75.6	90.2
Sensitivity (%)	67.8	91.5	98.3
Positive prognostic value	67.8	84.4	93.5
Negative prognostic value	53.7	86.1	97.4

Full Size Table

Citation: Jung E, Clevert D, Schreyer A, Schmitt S, Rennert J, Kubale R, Feuerbach S, Jung F. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007; 13(47): 6356-6364
URL: https://www.wjgnet.com/1007-9327/full/v13/i47/6356.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i47.6356

Jung E, Clevert D, Schreyer A, Schmitt S, Rennert J, Kubale R, Feuerbach S, Jung F. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007; 13(47): 6356-6364 [PMID: 18081224 DOI: 10.3748/wjg.v13.i47.6356]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.